ENTITY
CureVac NV

CureVac NV (CVAC US)

14
Analysis
Health Care • United States
CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.
more
Company Event • 29 May 2026 21:30 • Upcoming
Add To Calendar

Q4 2025

Company Event • 24 Nov 2025 20:00 • Upcoming
Add To Calendar

Q3 2025

Company Event • 16 Aug 2025 04:00 • Upcoming
Add To Calendar

Q2 2025

Company Event • 20 May 2025 14:00 • Upcoming
Add To Calendar

Q1 2025

Company Event • 15 May 2025 19:00 • Upcoming
Add To Calendar

Investor Presentation

x